The US Food and Drug Administration has dedicated a seventh new building at the White Oak Federal Research Center in Silver Spring, Maryland, as part of the agency consolidation project on the campus, to accommodate portions of the FDA's Commissioner and related executive functions.
Discussing the new building on his weekly blog, outgoing Commissioner Andrew von Eshenbach said "that what may look like construction of new buildings is actually the creation of a new future - a new future in the regulation of drugs, medical devices, vaccines and other FDA-regulated products that will save lives because of a modern, strong and efficient FDA. This campus is not merely a collection of offices and laboratories, but the creation of a critical mass of intellectual ability, incredible energy, and unparalleled dedication on the part of FDA scientists and experts that now have a new home at White Oak. During 2008, the number of FDA staff at White Oak Campus has grown to over 3,000. By 2012, there will be as many as 8,000 FDA employees working on this consolidated campus."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze